Aroa Biosurgery hopes for sales boost after study finds high healing rates

Aroa Biosurgery hopes for sales boost after study finds high healing rates
Aroa founder Brian Ward says the largest study to date of its tissue repair products bodes well for the firm. (Image: Aroa Biosurgery)
Rebecca Stevenson
Aroa Biosurgery founder Brian Ward says a new large study proving the efficacy and cost saving of its tissue repair products should help to convince conservative surgeons to use them. In late December Australian Securities Exchange (ASX) listed Aroa announced a peer-reviewed study of 120 inpatients for two of its treatments, Myriad Matrix and Myriad Morcells, in lower limb reconstructions. The study, which was published in a plastic and reconstructive surgery journal in December, found one application of Myriad achieved tissue coverag...

More Markets

Metroglass recap plan hands control to Amari Metals
Markets

Metroglass recap plan hands control to Amari Metals

An independent report said Metroglass was left with “no viable alternatives”.

Vital presses remaining shareholders to back takeover
Markets

Vital presses remaining shareholders to back takeover

Vital wants shareholders to accept “without delay”.

The problem with wet sock small caps
Markets

Eden Bradfield: The problem with wet sock small caps

Why are smaller firms better off as private companies?

Eden Bradfield 09 Aug 2025
Late selling drives NZ sharemarket down
Markets Market Close

Late selling drives NZ sharemarket down

There were 72 rises and 52 falls on the main board.

Jamie Gray 08 Aug 2025